agilon health, inc. (NYSE:AGL) Receives $4.03 Consensus Price Target from Brokerages

Shares of agilon health, inc. (NYSE:AGL) have received an average rating of “Hold” from the eighteen brokerages that are currently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, fourteen have assigned a hold recommendation and two have assigned a buy recommendation to the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $4.03.

AGL has been the topic of several recent analyst reports. William Blair cut shares of agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. Sanford C. Bernstein increased their target price on shares of agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a report on Wednesday, January 15th. Macquarie started coverage on agilon health in a report on Monday, December 16th. They set a “neutral” rating and a $3.00 price target on the stock. Stifel Nicolaus cut their price objective on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a research report on Tuesday, November 12th. Finally, Bank of America lowered agilon health from a “buy” rating to an “underperform” rating and set a $3.00 price target for the company. in a research note on Wednesday, October 2nd.

Insider Buying and Selling

In other news, Director John William Wulf acquired 45,000 shares of the business’s stock in a transaction that occurred on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the acquisition, the director now directly owns 206,133 shares of the company’s stock, valued at approximately $449,369.94. The trade was a 27.93 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Karen Mcloughlin bought 25,000 shares of the company’s stock in a transaction on Friday, December 13th. The stock was purchased at an average cost of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the transaction, the director now directly owns 73,166 shares of the company’s stock, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders acquired 90,000 shares of company stock worth $198,100. 3.20% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the company. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of agilon health during the 3rd quarter worth approximately $28,000. Oak Thistle LLC bought a new position in agilon health during the fourth quarter valued at $25,000. City State Bank purchased a new position in shares of agilon health in the 3rd quarter worth $52,000. Quarry LP increased its holdings in shares of agilon health by 500.3% in the 2nd quarter. Quarry LP now owns 18,254 shares of the company’s stock worth $119,000 after buying an additional 15,213 shares during the last quarter. Finally, Aigen Investment Management LP purchased a new stake in shares of agilon health during the 3rd quarter valued at about $79,000.

agilon health Price Performance

AGL stock opened at $3.69 on Friday. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The firm has a market cap of $1.52 billion, a P/E ratio of -3.92 and a beta of 0.53. The firm’s fifty day moving average is $2.22 and its 200 day moving average is $3.58. agilon health has a 52 week low of $1.50 and a 52 week high of $7.73.

agilon health (NYSE:AGL) last released its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the prior year, the firm posted ($0.06) EPS. Research analysts predict that agilon health will post -0.59 earnings per share for the current year.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.